Oxford malaria vaccine licensed for use in Ghana
by Press Release from Outbreak News Today on (#6AS8W)
NewsDesk @bactiman63 The University of Oxford-developed and Serum Institute of India PvT Ltd (SIIPL)- manufactured and scaled up R21/Matrix-MTM malaria vaccine, leveraging Novavax's adjuvant technology, has been licensed for use in Ghana by the country's Food and Drugs Authority. This marks the first regulatory clearance for the R21/Matrix-M malaria vaccine for use in any country. The successful [...]
The post Oxford malaria vaccine licensed for use in Ghana appeared first on Outbreak News Today.